Facioscapulohumeral muscular dystrophy is a genetically acquired disease that leads to progressive muscle weakness and severely decreased functional capacity in affected individuals—the understanding of how the interplay of epigenetic factors has evolved substantially in recent years. This activity reviews the current knowledge of the etiology and epidemiology of facioscapulohumeral muscular dystrophy. This activity outlines the evaluation and treatment of facioscapulohumeral muscular dystrophy and explains the role of the interprofessional team in improving the care of patients with this condition.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/21572
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABOS - 1.0 Point; Credit Type(s): Accredited CME (ABOS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP)
ABOHNS - 1.0 Point; Credit Type(s): Self-Assessment (ABOHNS) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Adolescent Medicine, Foot and Ankle, General Orthopaedics, General Pediatrics, General Surgery, Internal Medicine, Molecular Genetic Pathology, Neurotology, Otology, Pediatric Orthopaedic Surgery, Shoulder and Elbow, Soft Tissue & Bone, Surgery of the Spine
Subscribe
Login
0 Comments
Oldest